HRM, FLIP, and Prucalopride for Dysphagia
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore new methods for understanding and treating swallowing difficulties (dysphagia) by examining esophageal movement and response to food. Researchers will employ advanced technology, including FLIP (Functional Lumen Imaging Probe) and HRM (High-Resolution Manometry), to study the esophagus's structure and movement, with the goal of finding better ways to predict and treat this condition. Individuals who frequently experience difficulty swallowing, chest pain, or food impaction may be suitable candidates for this trial. Participants will undergo specific procedures to assess their esophageal function. The ultimate goal is to enhance treatments for conditions like functional dysphagia and GERD (gastroesophageal reflux disease).
As an unphased trial, this study offers participants the chance to contribute to groundbreaking research that could lead to new treatment options for swallowing difficulties.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that these techniques are safe for studying dysphagia?
Studies have shown that the Functional Lumen Imaging Probe (FLIP) is a safe tool for diagnosing swallowing problems. It measures the size and pressure in the esophagus in real time. FLIP is often used during procedures with sedation and performs well even with common sedatives. This capability allows doctors to make quick decisions safely without extra risks.
High-Resolution Manometry (HRM) is also safe and generally easy to handle. Most people experience no trouble with it. Only about 1 in 100 patients find it difficult, with this being more common in children. For adults with swallowing issues, HRM provides a reliable way to assess esophageal function, aiding doctors in understanding and treating these problems more effectively.
For those considering participation in a trial using these tools, research suggests that both FLIP and HRM are safe options for examining swallowing issues.12345Why are researchers excited about this trial?
Researchers are excited about the trial for dysphagia because it explores the use of high-resolution manometry (HRM) and functional lumen imaging probe (FLIP) as diagnostic tools, alongside the use of prucalopride. Unlike traditional treatments that focus mainly on swallowing exercises or dietary changes, HRM and FLIP provide a detailed look at the muscle function and structure of the esophagus, potentially leading to more precise diagnoses. Prucalopride, a prokinetic agent, could improve esophageal motility by enhancing bowel movements, which is different from standard treatments. This combination of advanced diagnostic techniques and a novel therapeutic approach could pave the way for more effective management of dysphagia.
What evidence suggests that FLIP and HRM could be effective for dysphagia?
Research has shown that both FLIP (Functional Lumen Imaging Probe) and HRM (High-Resolution Manometry) are promising tools for understanding and addressing swallowing difficulties, known as dysphagia. Studies indicate that FLIP effectively measures the size and pressure of the esophagus, helping to identify issues when other tests are unclear. In a study of 175 patients, certain FLIP measurements linked to symptoms of dysphagia. Meanwhile, HRM detected major movement problems in the esophagus in about 70% of patients with swallowing difficulties. These techniques are crucial for diagnosing and understanding dysphagia and could lead to better treatment options.
In this trial, researchers will study all participants using both FLIP and HRM to further explore their effectiveness in diagnosing and understanding dysphagia.12567Are You a Good Fit for This Trial?
This trial is for individuals experiencing swallowing difficulties, including those with primary achalasia or other related conditions. Participants should have symptoms that align with the study's focus on esophageal motor disorders and be willing to undergo novel diagnostic assessments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo various diagnostic and treatment procedures including prucalopride treatment, FLIP with manometry, and esophagram evaluation
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of esophageal clearance and recoil
Extension
Participants may undergo additional procedures if initial treatment targets are not met, such as repeat POEM
What Are the Treatments Tested in This Trial?
Interventions
- FLIP
- HRM
Find a Clinic Near You
Who Is Running the Clinical Trial?
Northwestern University
Lead Sponsor
The California Medical Innovations Institute, Inc.
Collaborator